Group 1 - The core point of the news is that Fengbei Biotechnology experienced a significant stock price increase of 172.60% on November 5, with a trading volume of 1.65 billion yuan [1] - As of November 5, the company had a total financing balance of 37.91 million yuan, which represents 1.83% of its market capitalization [1] - The company reported a revenue of 2.251 billion yuan for the period from January to September 2025, reflecting a year-on-year growth of 62.32% [2] Group 2 - The company was established on July 25, 2014, and is primarily engaged in the comprehensive utilization of waste oil resources, with a significant portion of its revenue coming from bio-based materials [1] - The number of shareholders for Fengbei Biotechnology reached 55,500 as of November 5, marking an increase of 792,357.14% compared to the previous period [2] - The company's main business revenue composition includes 91.18% from waste resource utilization, with bio-based materials accounting for 79.60% of that [1]
丰倍生物11月5日获融资买入4173.82万元，融资余额3790.99万元